Biosafe SA

Biosafe is proud to announce that its new generation Sepax 2 cell separation system has been approved for distribution in Japan as a class I medical device according to the Pharmaceutical Affairs Law (PAL). This additional milestone will further extend our presence in the Asia-Pacific market as the supplier of the only fully-automated cell processing platform. The original Sepax device was launched in 2001 and cleared by the Japanese authorities in 2007.